Fig. 3From: Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive studyTypes of PNS in patients diagnosed with the syndrome after the initiation of anti-PD-1 or anti-PD-L1 immunotherapy (cohort 2). PNS: paraneoplastic syndromeBack to article page
